Table 2:

PEP Efficacy Study Design

Group	No. of Animals	Vaccine, Dilution	Vaccination Days Post-Challenge	Ciprofloxacin Treatment
1	18	AV7909, 1:4
2	18	AV7909, 1:16
3	18	AV7909, 1:64
41	17	AV7909, 1:128	1,8	7.5 mg/kg, TID, 14 days
5	18	AV7909, 1:256
6	18	AVA, 1:16
7	18	Normal Saline
8	14	None	None	None

¹One group 4 animal was removed from the study due to a non-study-related reason; as a result, group 4 had 17 animals instead of the 18 animals.